The University of Southampton
University of Southampton Institutional Repository

The effect of the level and timing of folic acid supplementation during the life course on the regulation of breast cancer determining genes, mammary morphology and implications for genome stability and tissue differentiation

The effect of the level and timing of folic acid supplementation during the life course on the regulation of breast cancer determining genes, mammary morphology and implications for genome stability and tissue differentiation
The effect of the level and timing of folic acid supplementation during the life course on the regulation of breast cancer determining genes, mammary morphology and implications for genome stability and tissue differentiation
Folic acid (FA) intake has increased over the past decade; however, there are concerns that high levels of FA, particularly during early life, may increase breast cancer risk. Here a murine model has been used to directly test FA intake during specific periods of the life-course on the regulation of key cancer determining genes, Oct-4 and Brca1, polycomb regulator genes Ezh2, Bmi1 and Suz12, mammary gland morphology and protein expression.

Female C57BL/6 mice were fed a modified AIN93M semi-purified diet containing either 1 mg/kg (1x basal daily recommendation (BDR): 5 mg/kg (5 x BDR), 20 mg/kg (20 x BDR) or a FA deficient diet containing 0.2 mg/kg (0.2 x BDR) for a 4 week period during either the juvenile-pubertal (JP) period or adulthood (A). After this period mice were fed an AIN93M maintenance diet for 4 or 12 weeks. The 2nd and 3rd thoracic mammary glands were collected and mRNA expression of Brca1, Oct-4, Ezh2, Bmi1 and Suz12 measured by quantitative real time PCR (qRT-PCR). Levels of Ezh2 protein and its target H3K27 (tri-methyl) were quantified by Western Blot. Mammary gland epithelial morphology was assessed using mammary whole mounts. Epithelial tree density, branch length, branch junctions and number of terminal end buds (TEBs) were calculated. Genome wide differential gene expression was investigated using RNA-seq in juvenile or adult mice fed 5 mg/kg FA 4 weeks post supplementation. Mammary Oct-4, Brca1, basal/myoepithelial marker α-smooth muscle actin (α-SMA), luminal marker keratin 8 (K8), cell proliferation marker Ki67 and driver of luminal differentiation Gata-3 proteins were investigated with immunohistochemistry using 3,3’-diaminobenzidine and immunofluorescence.

A persistent increase in Brca1, Oct-4, Ezh2, Bmi1 and Suz12 gene expression after FA supplementation at 5 mg/kg was observed during A. In contrast, FA supplementation at 5 mg/kg during JP led to a decrease in Oct-4 gene expression. FA supplementation at 5 mg/kg increased levels of Ezh2 protein and levels of H3K27 (tri-methyl) during A. Mammary morphology was largely unchanged; however, epithelial density and number of TEBs showed a persistent increase in JP supplemented mice. Brca1, and Oct-4 proteins were found to be localised in mammary epithelial ducts. Numbers of basal/myoepithelial cells expressing α-SMA were unchanged, however, numbers of cells expressing cell proliferation marker Ki67 increased. RNA-seq analysis identified differential expression in genes associated with extracellular matrix, enriched gene sets included epithelial mesenchymal transition (EMT) and pathways associated with matrix metalloproteinases (MMPs), extracellular matrix components and cancer during A. Interestingly, juvenile mice showed distinct gene sets with minimal overlap with those during A.

JP and adult FA supplementation induce tissue specific alterations in expression of key cancer genes that persist beyond the period of supplementation. The effects of FA are both dose and timing specific and imply that the ability of FA to modify cancer risk extends beyond recent diet and may, in part, reflect intakes during different periods of mammary plasticity. These findings suggest high folic acid intake in mice may increase breast cancer risk especially when consumed during adulthood.
University of Southampton
Burton, Mark Andrew
250319ad-90dc-4651-b118-d5dbe5eaafa6
Burton, Mark Andrew
250319ad-90dc-4651-b118-d5dbe5eaafa6
Lillycrop, Karen
eeaaa78d-0c4d-4033-a178-60ce7345a2cc

Burton, Mark Andrew (2016) The effect of the level and timing of folic acid supplementation during the life course on the regulation of breast cancer determining genes, mammary morphology and implications for genome stability and tissue differentiation. University of Southampton, Doctoral Thesis, 471pp.

Record type: Thesis (Doctoral)

Abstract

Folic acid (FA) intake has increased over the past decade; however, there are concerns that high levels of FA, particularly during early life, may increase breast cancer risk. Here a murine model has been used to directly test FA intake during specific periods of the life-course on the regulation of key cancer determining genes, Oct-4 and Brca1, polycomb regulator genes Ezh2, Bmi1 and Suz12, mammary gland morphology and protein expression.

Female C57BL/6 mice were fed a modified AIN93M semi-purified diet containing either 1 mg/kg (1x basal daily recommendation (BDR): 5 mg/kg (5 x BDR), 20 mg/kg (20 x BDR) or a FA deficient diet containing 0.2 mg/kg (0.2 x BDR) for a 4 week period during either the juvenile-pubertal (JP) period or adulthood (A). After this period mice were fed an AIN93M maintenance diet for 4 or 12 weeks. The 2nd and 3rd thoracic mammary glands were collected and mRNA expression of Brca1, Oct-4, Ezh2, Bmi1 and Suz12 measured by quantitative real time PCR (qRT-PCR). Levels of Ezh2 protein and its target H3K27 (tri-methyl) were quantified by Western Blot. Mammary gland epithelial morphology was assessed using mammary whole mounts. Epithelial tree density, branch length, branch junctions and number of terminal end buds (TEBs) were calculated. Genome wide differential gene expression was investigated using RNA-seq in juvenile or adult mice fed 5 mg/kg FA 4 weeks post supplementation. Mammary Oct-4, Brca1, basal/myoepithelial marker α-smooth muscle actin (α-SMA), luminal marker keratin 8 (K8), cell proliferation marker Ki67 and driver of luminal differentiation Gata-3 proteins were investigated with immunohistochemistry using 3,3’-diaminobenzidine and immunofluorescence.

A persistent increase in Brca1, Oct-4, Ezh2, Bmi1 and Suz12 gene expression after FA supplementation at 5 mg/kg was observed during A. In contrast, FA supplementation at 5 mg/kg during JP led to a decrease in Oct-4 gene expression. FA supplementation at 5 mg/kg increased levels of Ezh2 protein and levels of H3K27 (tri-methyl) during A. Mammary morphology was largely unchanged; however, epithelial density and number of TEBs showed a persistent increase in JP supplemented mice. Brca1, and Oct-4 proteins were found to be localised in mammary epithelial ducts. Numbers of basal/myoepithelial cells expressing α-SMA were unchanged, however, numbers of cells expressing cell proliferation marker Ki67 increased. RNA-seq analysis identified differential expression in genes associated with extracellular matrix, enriched gene sets included epithelial mesenchymal transition (EMT) and pathways associated with matrix metalloproteinases (MMPs), extracellular matrix components and cancer during A. Interestingly, juvenile mice showed distinct gene sets with minimal overlap with those during A.

JP and adult FA supplementation induce tissue specific alterations in expression of key cancer genes that persist beyond the period of supplementation. The effects of FA are both dose and timing specific and imply that the ability of FA to modify cancer risk extends beyond recent diet and may, in part, reflect intakes during different periods of mammary plasticity. These findings suggest high folic acid intake in mice may increase breast cancer risk especially when consumed during adulthood.

Text
Mark Andrew Burton Final Thesis March 2017 - Version of Record
Available under License University of Southampton Thesis Licence.
Download (9MB)

More information

Published date: October 2016
Organisations: University of Southampton, Centre for Biological Sciences

Identifiers

Local EPrints ID: 407459
URI: http://eprints.soton.ac.uk/id/eprint/407459
PURE UUID: 5f19649b-30c4-405e-ba5e-f4cd16fb5eae
ORCID for Mark Andrew Burton: ORCID iD orcid.org/0000-0002-7117-8151
ORCID for Karen Lillycrop: ORCID iD orcid.org/0000-0001-7350-5489

Catalogue record

Date deposited: 12 Apr 2017 01:03
Last modified: 09 Jul 2024 01:53

Export record

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×